RTW Charitable Foundation Accelerator
The RTW Charitable Foundation Accelerator ran from 2021-2022, and is currently dormant.
The program was administered by Columbia Technology Ventures, and was strategic research alliance between the RTW Charitable Foundation and select New York-based academic institutions, to accelerate translational research in the field of rare diseases with particular interest in ultra-rare and underfunded rare diseases.
Questions? Please read Program Information below or reach out to the Maria Rahmany at [email protected].
Program Information
Translational projects focused on treatment of rare and ultra-rare diseases in the following areas:
- Central Nervous System
- Cardiovascular
- Immunology/Autoimmunity (non-oncology)
Projects were aimed towards developing treatments or technologies to improve patient lives.
About RTW Charitable Foundation
The RTW Charitable Foundation (RTWCF) works to improve opportunities for all people to live healthier, longer lives and was created at the intersection of scientific advancements and humanitarian efforts. RTWCF is proud to support pioneers who are breaking new ground in the fight against diseases that may not represent compelling commercial opportunities but do result in significant human suffering. The Foundation can provide capital, collaborative leadership, and scientific expertise to help scientists push such projects forward. In addition, the Foundation aims to assist in advocacy, disease awareness and direct support to patients and their families.
For more information, visit rtwcf.org.